The Asia‐Pacific AMS800 artificial urinary sphincter consensus statement

作者：Eric Chung, Limin Liao, Jang Hwan Kim, Zhong Wang, Takeya Kitta, Alex Tong‐Long Lin, Kyu‐Sung Lee, Liefu Ye, Peggy Chu, Yasuhiro Kaiho, Mineo Takei, Hai Jiang, Joe Lee, Hitoshi Masuda, Vincent Tse · 发表于：International Journal of Urology · 年份：2022 · DOI：10.1111/iju.15083 · 被引用次数：19 · 研究领域：Pelvic floor disorders treatments、Prostate Cancer Diagnosis and Treatment、Urological Disorders and Treatments

This Asia-Pacific (AP) AMS 800™ artificial urinary sphincter (AUS) consensus statement aims to provide a set of practical recommendations to assist surgeons with the AMS 800 device surgery. The AP consensus committee consisted of key opinion leaders with extensive experience with AMS 800 surgery across several AP countries. The panel reviewed and discussed relevant findings with emphasis on locoregional and specific clinical challenges relevant to the AP region. Recommendations were made in key areas namely (1) patient selection and informed consent process; (2) preoperative assessment; (3) dealing with co-existing urological disorders; (4) surgical principles and intraoperative troubleshooting; (5) postoperative care; (6) special populations; and (7) cost analysis and comparative review. The AMS 800 device should be offered to males with moderate to severe stress urinary incontinence (SUI). Full informed consent should be undertaken, and emphasis is placed on surgical contraindications and high-risk candidates. The presence of a surgical mentor or referral to experts is recommended in complex AUS candidates. Preoperative cystoscopy with or without multichannel urodynamic study is necessary and patients with pre-existing urological disorders should be treated adequately and clinically stable before surgery. Adherence to strict patient selection and safe surgical principles are critical to ensure excellent clinical outcomes and minimize complications. Given that InhibiZone-coa...